(Q35090200)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Porphyrin conjugated with serum albumins and monoclonal antibodies boosts efficiency in targeted destruction of human bladder cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

José A.S. Cavaleiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Rudolf J Schneider

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Rosa Fernandes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Joao Tome

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

José J Carvalho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sandrina Silva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

Organic and Biomolecular Chemistry

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1804-1811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24513883%20AND%20SRC:MED&resulttype=core&format=json

Photodynamic therapy of cancer: an update

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Enhancement of the photodynamic activity of tri-cationic porphyrins towards proliferating keratinocytes by conjugation to poly-S-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Chain-dependent photocytotoxicity of tricationic porphyrin conjugates and related mechanisms of cell death in proliferating human skin keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Overview of targeted therapies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Scavenger-receptor targeted photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Porphyrin, chlorin, and bacteriochlorin isothiocyanates: useful reagents for the synthesis of photoactive bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Photosensitiser-antibody conjugates for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Immunotherapy: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Synthesis and antibacterial activity of new poly-S-lysine-porphyrin conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

In vitro and in vivo photosensitization by protoporphyrins possessing different lipophilicities and vertical localization in the membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E

Reactive oxygen species downregulate glucose transport system in retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42082E